RJA
MLAB icon

Raymond James & Associates’s Mesa Laboratories MLAB Stock Holding History

Raymond James & Associates’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$9.98M Sell
76,855
-3,884
-5% -$457K 0.01% 1236
2024
Q2 		$7.01M Buy
80,739
+6,283
+8% +$658K ﹤0.01% 1362
2024
Q1 		$8.17M Buy
74,456
+27,437
+58% +$2.76M 0.01% 1273
2023
Q4 		$4.93M Sell
47,019
-20,407
-30% -$1.99M ﹤0.01% 1544
2023
Q3 		$7.08M Buy
67,426
+1,984
+3% +$254K 0.01% 1252
2023
Q2 		$8.41M Buy
65,442
+2,209
+3% +$337K 0.01% 1159
2023
Q1 		$11M Buy
63,233
+5,102
+9% +$914K 0.01% 976
2022
Q4 		$9.66M Buy
58,131
+11,693
+25% +$1.83M 0.01% 1014
2022
Q3 		$6.54M Buy
46,438
+1,719
+4% +$314K 0.01% 1201
2022
Q2 		$9.12M Buy
44,719
+10,022
+29% +$2.19M 0.01% 1032
2022
Q1 		$8.84M Buy
34,697
+4,656
+15% +$1.26M 0.01% 1135
2021
Q4 		$9.86M Buy
30,041
+3,792
+14% +$1.19M 0.01% 1117
2021
Q3 		$7.94M Buy
26,249
+7,266
+38% +$2.07M 0.01% 1191
2021
Q2 		$5.15M Buy
18,983
+3,185
+20% +$808K ﹤0.01% 1478
2021
Q1 		$3.85M Buy
15,798
+4,486
+40% +$1.23M ﹤0.01% 1597
2020
Q4 		$3.24M Buy
11,312
+598
+6% +$165K ﹤0.01% 1587
2020
Q3 		$2.73M Buy
10,714
+1,992
+23% +$473K ﹤0.01% 1566
2020
Q2 		$1.89M Buy
+8,722
New +$2.01M ﹤0.01% 1767

Other funds holding MLAB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Raymond James & Associates's MLAB Position: Q3 2024 in Review

Raymond James & Associates reduced its Mesa Laboratories (MLAB) stake by 4.8% in Q3 2024, selling an estimated $457K and leaving 76,855 shares worth $9.98M. The position accounts for 0.01% of the portfolio, ranked #1236.

Raymond James & Associates first reported a position in MLAB in Q2 2020 and has held it in 18 quarters since. The position peaked at $11M in Q1 2023. 166 funds tracked by Wall St. Rank hold MLAB as of Q3 2024.

  • Raymond James & Associates held 76,855 shares of Mesa Laboratories worth $9.98M as of Q3 2024.
  • Raymond James & Associates sold 3,884 Mesa Laboratories shares in Q3 2024, an estimated $457K.
  • Mesa Laboratories made up 0.01% of Raymond James & Associates's portfolio in Q3 2024, its #1236 holding.
  • Raymond James & Associates first reported a position in Mesa Laboratories in Q2 2020 and has held it in 18 quarters since.
  • Raymond James & Associates's Mesa Laboratories position peaked at $11M in Q1 2023.
  • 166 funds tracked by Wall St. Rank held Mesa Laboratories as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.